ArticleProceedings of the National Academy of Sciences of the United States of America2021

Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration.

Meenakshi Ambati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.